Hyperspectral imaging of atherosclerotic plaques in vitro

Journal of Biomedical Optics

Volumn 16, Issue 2, 2011, Pages

  Larsen, Eivind L P ^a   Randeberg, Lise L ^a,b   Olstad, Elisabeth ^b   Haugen, Olav A ^a   Aksnes, Astrid ^a   Svaasand, Lars O ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Atherosclerosis; Hyperspectral imaging; Optical diagnostics

Indexed keywords

ATHEROSCLEROSIS; ATHEROSCLEROTIC LESIONS; ATHEROSCLEROTIC PLAQUE; DIAGNOSTIC INFORMATION; HYPER-SPECTRAL IMAGES; HYPERSPECTRAL DATA; HYPERSPECTRAL IMAGING; IN-VITRO; K-MEANS CLUSTERING; MINIMUM NOISE FRACTION; OPTICAL CHARACTERIZATION; OPTICAL DIAGNOSTICS; SINGLE POINT; SPATIAL INFORMATIONS; SPECTROSCOPIC MEASUREMENTS; STATISTICAL IMAGES; ULTRAVIOLET ILLUMINATION; VULNERABLE PLAQUES; WHITE LIGHT;

BIOMINERALIZATION; BLOOD VESSELS; DATA HANDLING; IMAGE ANALYSIS;

PRINCIPAL COMPONENT ANALYSIS;

AGED; AORTA VALVE STENOSIS; ARTICLE; ATHEROSCLEROSIS; EQUIPMENT; EQUIPMENT DESIGN; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; INSTRUMENTATION; MALE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPECTROFLUOROMETRY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; ATHEROSCLEROSIS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE;

EID: 79957863234     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3540657     Document Type: Article

References (49)

1. D. Lloyd-Jones, R. Adams, M. Carnethon, G. D. Simone, T. B. Ferguson, K. Flegal, E. Ford, K. Furie, A. Go, K. Greenlund, N. Haase, S. Hailpern, M. Ho, V. Howard, B. Kissela, S. Kittner, D. Lackland, L. Lisabeth, A. Marelli, M. McDermott, J. Meigs, D. Mozaffarian, G. Nichol, C. O'Donnell, V. Roger, W. Rosamond, R. Sacco, P. Sorlie, R. Stafford, J. Steinberger, T. Thom, S. Wasserthiel-Smoller, N. Wong, J. Wylie-Rosett, and Y. Hong, "Heart disease and stroke statistics-2009 update. A report from the American Heart Association statistics committee and stroke statistics subcommittee," Circulation 119, e21-e181 (2009).
2. P. R. Moreno, R. A. Lodder, R. Purushothaman, W. E. Charash, W. N. O'Connor, and J. E. Muller," Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by nearinfrared spectroscopy," Circulation 105, 923-927 (2002).
3. M. B. Lilledahl, O. A. Haugen, M. Barkost, and L. O. Svaasand, "Reflection spectroscopy of atherosclerotic plaque," J. Biomed. Opt. 11(2), 021005 (2006).
4. G. O. Angheloiu, J. T. Arendt, M. G. Müller, A. S. Haka, I. Georgakoudi, J. T. Motz, O. R. Scepanovic, B. D. Kuban, J. Myles, F. Miller, E. A. Podrez, M. Fitzmaurice, J. R. Kramer, and M. S. Feld, "Intrinsic fluorescence and diffuse reflectance spectroscopy identify superficial foam cells in coronary plaques prone to erosion," Arterioscl. Throm. Vas. 26, 1594-1600 (2006).
5. C. Kittrell, R. L. Willett, C. de los Santos-Pacheo, N. B. Ratliff, J. R. Kramer, E. G. Malk, and M. S. Feld, "Diagnosis of fibrous arterial atherosclerosis using fluorescence," Appl. Opt. 24(15), 2280-2281 (1985).
6. S. Andersson-Engels, J. Johansson, U. Stenram, K. Svanberg, and S. Svanberg, "Malignant tumor and atherosclerotic plaque diagnosis using laser-induced fluorescence," IEEE J. Quantum Electron. 26(12), 2207-2217 (1990).
7. T. G. Papazoglou, "Malignancies and atherosclerotic plaque diagnosis: is laser induced fluorescence spectroscopy the ultimate solution," J. Photochem. Photobiol. B 28, 3-11 (1995).
8. N. Anastassopoulou, B. Arapoglou, P. Demakakos, M. I. Makropoulou, A. Paphiti, and A. A. Serafetinides, "Spectroscopic characterisation of carotid atherosclerotic plaque by laser induced fluorescence," Lasers Surg. Med. 28, 67-73 (2001).
9. M. E. Brezinski, G. J. Tearney, B. E. Bouma, J. A. Izatt, M. R. Hee, E. A. Swanson, J. F. Southern, and J. G. Fujimoto, "Optical coherence tomography for optical biopsy: properties and demonstration of vascular pathology," Circulation 93, 1206-1213 (1996).
10. I.-K. Jang, G. J. Tearney, B. MacNeill, M. Takano, F. Moselewski, N. Iftima, M. Shishkov, S. Houser, H. T. Aretz, E. F. Halpern, and B. E. Bouma, "In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography," Circulation 111, 1551-1555 (2005).
11. C. T. Sherman, F. Litvack, W. Grundfest, M. Lee, A. Hickey, A. Chaux, R. Kass, C. Blanche, J. Matloff, L. Morgenstern, W. Ganz, H. J. C. Swan, and J. Forrester, "Coronary angioscopy in patients with unstable angina pectoris," N. Engl. J. Med. 315, 913-919 (1986).
12. M. Asakura, Y. Ueda, O. Yamaguchi, T. Adachi, A. Hirayama, M. Hori, and K. Kodama, "Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: An angioscopic study," J. Am. Coll. Cardiol. 37(5), 1284-1288 (2001).
13. P. D. Beule, D. M. Owen, H. B. Manning, C. B. Talbot, J. Requejo-Isidro, C. Dunsby, J. Mcginty, R. K. P. Benninger, D. S. Elson, I. Munro, M. J. Lever, P. Anand, M. A. A. Neil, and P. M. W. French, "Rapid hyperspectral fluorescence lifetime imaging," Microsc. Res. Tech. 70(5), 481-484 (2007).
14. M. B. Lilledahl, O. A. Haugen, C. de Lange Davies, and L. O. Svaasand, "Characterization of vulnerable plaques by multiphoton microscopy," J. Biomed. Opt. 12(4), 044005 (2007).
15. B. Khoobehi, J. M. Beach, and H. Kawano, "Hyperspectral imaging for measurement of oxygen saturation in the optic nerve head," Inv. Opth. Vis. Sci. 45(5), 1464-1472 (2004).
16. W. R. Johnson, D. W. Wilson, W. Fink, M. Humayun, and G. Bearman, "Snapshot hyperspectral imaging in opthalmology," J. Biomed. Opt. 12(1), 014036 (2007).
17. B. Farina, C. Bartoli, A. Bono, A. Colombo, M. Lualdi, G. Tragni, and R. Marchesini, "Multispectral imaging approach in the diagnosis of cutaneous melanoma: potentiality and limits," Phys. Med. Biol. 45, 1243-1254 (2000).
18. L. L. Randeberg, I. Baarstad, T. Løke, P. Kaspersen, and L. O. Svaasand, "Hyperspectral imaging of bruised skin," Proc. SPIE 6078, 60780O (2006).
19. G. N. Stamatas and N. Kollias, "In vivo documentation of cutaneous inflammation using spectral imaging," J. Biomed. Opt. 12(5), 051603 (2007).
20. A. Vogel, V. V. Chernomordik, J. D. Riley, M. Hassan, F. Amyot, B. Dasgeb, S. G. Demos, R. Pursley, R. F. Little, R. Yarchoan, T. Tao, and A. H. Gandjbakhche, "Using noninvasive multispectral imaging to quantitatively assess tissue vasculature," J. Biomed. Opt. 12(5), 051604 (2007).
21. D. G. Ferris, R. A. Lawhead, E. D. Dickman, N. Holtzapple, J. A. Miller, S. Grogan, S. Bambot, A. Agrawal, and M. L. Faupel, "Multimodal hyperspectral imaging for the noninvasive diagnosis of cervical neoplasia," J. Low Genit. Tract. Dis. 5(2), 65-72 (2001).
22. M. E. Martin, M. B. Wabuyele, K. Chen, P. Kasili, M. Panjehpour, M. Phan, B. Overholt, G. Cunningham, D. Wilson, R. C. DeNovo, and T. Vo-Dinh, "Development of an hyperspectral imaging (hsi) system with applications for cancer detection," Ann. Biomed. Eng. 34(6), 1061-1068 (2006).
23. B. S. Sorg, M. E. Hardee, N. Agarwal, B. J. Moeller, and M. W. Dewhirst, "Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumors," J. Biomed. Opt. 13(1), 014026 (2008).
24. A. M. Siddiqi, H. Li, F. Faruque, W. Williams, K. Lai, M. Hughson, S. Bigler, J. Beach, and W. Johnson, "Use of hyperspectral imaging to distinguish normal, precancerous, and cancerous cells," Cancer Cytopathol. 114(1), 13-21 (2008).
25. M. E. Martin, M. B. Wabuyele, M. Panjehpour, M. N. Phan, B. F. Overholt, and T. Vo-Dinh, "Hyperspectral fluorescence imaging system for biomedical diagnostics," Proc. SPIE 6080, 60800Q (2006).
26. G. Zavattini, S. Vecchi, G. Mitchell, U. Weisser, R. M. Leahy, B. J. Pichler, D. J. Smith, and S. R. Cherry, "A hyperspectral fluorescence system for 3d in vivo optical imaging," Phys. Med. Biol. 51, 2029-2043 (2006).
27. M. E. Martin, M. Wabuyele, M. Panjehpour, B. Overholt, R. DeNovo, S. Kennel, G. Cunningham, and T. Vo-Dinh, "An AOTF-based dual-modality hyperspectral imaging system (DMHSI) capable of simultaneous fluorescence and reflectance imaging," IEEE Eng. Med. Biol. Mag. 28(2), 149-155 (2006).
28. "The vulnerable atherosclerotic plaque: Understanding, identification, and modification," in Clinical Photomedicine, V. Fuster, Ed., Chap. 1, American Heart Association, Monograph Series, Futura Publishing Company, Inc., Armonk, NY (1998).
29. M. Naghavi, P. Libby, E. Falk, S. W. Casscells, S. Litovsky, J. Rumberger, J. J. Badimon, C. Stefanadis, P. Moreno, G. Pasterkamp, Z. Fayad, P. H. Stone, S. Waxman, P. Raggi, M. Madjid, A. Zarrabi, A. Burke, C. Yuan, P. J. Fitzgerald, D. S. Siscovick, C. L. de Korte, M. Aikawa, K. E. J. Airaksinen, G. Assmann, C. R. Becker, J. H. Chesebro, A. Farb, Z. S. Galis, C. Jackson, I.-K. Jang, W. Koenig, R. A. Lodder, K. March, J. Demirovic, M. Navab, S. G. Priori, M. D. Rekhter, R. Bahr, S. M. Grundy, R. Mehran, A. Colombo, E. Boerwinkle, C. Ballantyne, W. Insull, R. S. Schwartz, R. Vogel, P. W. Serruys, G. K. Hansson, D. P. Faxon, S. Kaul, H. Drexler, P. Greenland, J. E. Muller, R. Virmani, P. M. Ridker, D. P. Zipes, P. K. Shah, and J. T. Willerson," From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies, part I," Circulation 108, 1664-1672 (2003).
30. H. C. Stary, A. B. Chandler, S. Glagov, J. R. Guyton, W. Insell Jr., M. E. Rosenfeld, S. A. Schaffer, C. J. Schwartz, W. D. Wagner, and R. W. Wissler, "A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association," Arterioscl. Throm. Vas. 14, 840-856 (1994).
31. H. C. Stary, A. B. Chandler, R. E. Dinsmore, V. Fuster, S. Glagov, W. Insull Jr., M. E. Rosenfeld, C. J. Schwartz, W. D. Wagner, and R. W. Wissler, "A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association," Circulation 92, 1355-1374 (1995).
32. R. Virmani, F. D. Kolodgie, A. P. Burke, A. Farb, and S. M. Schwartz, "Lessons from sudden coronary death. A comprehensive morphological classification scheme for atherosclerotic lesions," Arterioscl. Throm. Va s. 20, 1262-1275 (2000).
33. S. Prahl, "Optical absorption of Hemoglobin," Oregon Medical Laser Center, World Wide Web (1999). URL: http://omlc.ogi.edu/spectra/hemoglobin
34. W. G. Zijlstra, A. Buursma, and O. W. van Assendelft, "Visible and near infrared absorption spectra of human and animal haemoglobin," VSP (2000).
35. N. Kollias, A. Baqer, I. Sdiq, and T. M. Sayre, "In vitro and in vivo ultraviolet-induced alterations of oxy- and deoxyhemoglobin," Pho-tochem. Photobiol. 56(2), 223-227 (1992).
36. D. H. Blankenhorn, D. G. Freiman, and H. C. Knowles, "Carotenoids in man: the distribution of epiphasic carotenoids in atherosclerotic lesions," J. Clin. Invest. 35, 1243-1247 (1956).
37. H. Du, R.-C. A. Fuh, J. Li, L. A. Corkan, and J. S. Lindsey, "Photochemcad: A computer-aided design and research tool in photochemistry," Photochem. Photobiol. 68(2), 141-142 (1998).
38. W. Stahl, U. Heinrich, H. Jungmann, J. von Laar, M. Schietzel, H. Sies, and H. Tronnier, "Increased dermal carotenoid levels assessed by noninvasive reflection spectrophotometry correlate with serum levels in women ingesting Betatene," J. Nutr. 128(5), 903-907 (1998).
39. I. S. Saidi, S. L. Jacques, and F. K. Tittel, "Mie and rayleigh modelling of visible-light scattering in neonatal skin," Appl. Opt. 34(31), 7410-7418 (1995).
40. L. I. Laifer, K. M. O'Brien, M. L. Stetz, G. R. Gindi, T. J. Garrand, and L. I. Deckelbaum, "Biochemical basis for the difference between normal and atherosclerotic arterial fluorescence," Circulation 80, 1893-1901 (1989).
41. R. Richards-Kortum and E. Sevick-Muraca, "Quantitative optical spec-troscopy for tissue diagnosis," Annu. Rev. Phys. Chem. 47, 555-606 (1996).
42. T. Skauli, P. E. Goa, I. Baarstad, and T. Løke, "A compact combined hyperspectral and polarimetric imager," Proc. SPIE 6395, 639505 (2006).
43. ENVI User's Guide, pp. 684-688, Research Systems Inc., ENVI version 4.2 August ed. (2005).
44. J. T. Tou and R. C. Gonzalez, Pattern recognition principles, Addison-Wesley Publishing Company, Reading, MA (1974).
45. L. L. Randeberg, J. H. Bonesrønning, M. Dalaker, J. S. Nelson, and L. O. Svaasand, "Methemoglobin formation during laser induced photothermolysis of vascular skin lesions," Lasers Surg. Med. 34(5), 414-419 (2004).
46. E. Salomatina and A. N. Yaroslavsky, "Evaluation of the in vivo and ex vivo optical properties in a mouse ear model," Phys. Med. Biol. 53, 2797-2807 (2008).
47. A. J. Morguet, B. Körber, B. Abel, H. Hippler, V. Wiegand, and H. Kreuzer, "Autofluorescence spectroscopy using a XeCl excimer laser system for simultaneous plaque ablation and fluorescence excitation," Lasers Surg. Med. 14, 238-248 (1994).
48. L. Marcu, J. A. Jo, Q. Fang, T. Papaioannou, T. Reil, J.-H. Qiao, J. D. Baker, J. A. Freischlag, and M. C. Fishbein, "Detection of rup-tureprone atherosclerotic plaques by time-resolved laser-induced fluorescence spectroscopy," Ather. 204, 156-164 (2009).
49. M. B. Lilledahl, M. Barkost, M. W. Gran, O. A. Haugen, and L. O. Svaasand, "The effect of a thin bloodlayer on fluorescence spec-troscopy," Proc. SPIE 6078, 60782J (2006).